Drug Development Breakthroughs: From Novel Antimicrobials to Targeted Cancer Drugs
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 30 January 2026 | Viewed by 1107
Special Issue Editor
Interests: drug development; small-molecule inhibitors; miRNAs; antimicrobial compounds
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Transforming a potential drug from an idea to a marketable product on pharmacy shelves is a long, time-consuming, and expensive process. Recent advances in drug discovery and development, particularly with the integration of artificial intelligence, aim to make this process easier, faster, and safer. This Special Issue seeks to showcase the latest advancements in drug discovery and development, with a focus on molecular science. We welcome contributions that highlight, but are not limited to, novel small-molecule inhibitors, biopharmaceuticals, peptides, phytochemicals, and new antimicrobial compounds, alongside research on novel therapies for the treatment of cancer and cardiovascular and autoimmune diseases, among others. Submissions that combine clinical insights with molecular science approaches are especially encouraged, as they provide a deeper understanding of the mechanisms of action and biomolecular basis of drug effects. Pure clinical studies will not be suitable, although we are interested in research which bridges clinical applications with biomolecular findings. We invite comprehensive reviews or original research articles that explore innovative strategies in drug development, elucidating molecular pathways and their therapeutic potential.
Dr. Christos Papaneophytou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug development
- molecular science
- small-molecule inhibitors
- biopharmaceuticals
- peptides
- cancer therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
